PR92738

DUSSELDORF, Germany, Nov. 8, 2021 /PRNewswire=KYODO JBN/ --

Chinese biotechnology company Nanjing Vazyme Biotech Co., Ltd (Vazyme) will

exhibit its advanced COVID-19 testing products and solutions in Hall 3 Stand F

94 at MEDICA 2021, the world's leading trade fair for the medical sector, in

Messe Düsseldorf (Germany) from November 15 to November 18. The event provides

visitors with a broad range of innovative medical products and solutions

accompanied by ideas exchange and expert dialogues in specialist forums in

order to better understand the trends of the healthcare industry.

Vazyme will reveal its full lineup of COVID-19 related products and solutions

at the event, with a focus on the debut of the company's latest virus testing

product – SARS-CoV-2 & FLU A/B RT-QPCR and SARS-CoV-2 & FLU A/B Ag Rapid Test,

both of which are able to test and detect three types of virus including

COVID-19 and influenza A/B simultaneously, achieving more efficient and

comprehensive virus testing.

Since the pandemic hit, Vazyme has been constantly rolling out a series of

COVID-19 testing reagents and related devices for nucleic acid detection

solution, rapid antigen, rapid antibody, and rapid neutralizing antibody tests.

Vazyme's products improve COVID-19 testing in the fight against the crippling

pandemic with more accurate, reliable, and rapid testing results. Vazyme has

provided COVID-19 testing products and solutions to multiple countries and

regions including Germany, UK, Russia, Brazil, and Indonesia, and has supplied

key raw materials for over 500 million COVID-19 testing kits to testing kit

manufacturers globally.

Vazyme will showcase more COVID-19 diagnostic products and solutions including:

-Nucleic Acid Detection Solution

-SARS-CoV-2 Ag Rapid Test

-SARS-CoV-2 Ag Home Test

-SARS-CoV-2 & FLU A/B Ag Rapid Test

-Neutralizing Ab Detection

-Etc.

The global in vitro diagnostics market has seen remarkable growth, along with

the demands of comprehensive, accurate, customized diagnostic solutions. With

years of experience of developing products in this field, Vazyme's in vitro

diagnostic products have covered various specialties including cardiology,

prenatal and postnatal care, gastroenterology, nephrology, infection, and

pediatric pulmonology.

Apart from Point-of-Care Testing (POCT) diagnostic devices, as a leading

upstream medical raw material supplier, Vazyme aims to provide its clients with

the best products and services in medical raw materials. As one of the few

research and development (R&D)-focused innovative producers in China with

capabilities in developing upstream technologies in-house and manufacturing

finished products, Vazyme upholds the vision to improve human life with

technology and focuses on continuous investment in technological innovation and

quality products.

To further reach billions of customers globally, Vazyme is accelerating the

expansion of its footprint in overseas markets, with a focus on developing the

European market by building extensive local operations. Currently Vazyme is

working with world renowned academic institutions to establish multinational

labs and partnering with leading medical and pharmaceutical distributors in

overseas markets to build localized sales and distribution networks. Vazyme is

looking forward to engaging with more global partners at MEDICA 2021.

About Vazyme

Founded in 2012, Vazyme is one of the few R&D-focused innovative biotechnology

firms in China that has capabilities in developing upstream technologies

in-house and manufacturing finished products. With an ongoing commitment to

innovation and based on its proprietary key generic technology platform, the

company has built a business network spanning biological research, in vitro

diagnosis and biomedicine. Vazyme has developed eight series of proprietary

POCT diagnostic reagents and related control materials covering cardiovascular

and cerebrovascular diseases, inflammation, prepotency, gastric functions,

autoimmunity, renal functions, chronic disease management as well as

respiratory diseases.

For more information, please visit Vazyme's official website at

http://www.vazyme.com

Source: Vazyme

Image Attachments Links:

   Link: http://asianetnews.net/view-attachment?attach-id=406002